Gynaecological Cancer Charity, The Eve Appeal, Becomes First Winner of Patient Partnership Index (PPI) Ask Eve Assist, The Eve Appeal’s AI tool to tackle the gynaecological health backlog, is the first winner of the Patient Partnership Index (PPI) The PPI is OVID Health’s global initiative to evaluate and celebrate partnerships between patient groups and the …
An OVID Health article by Ollie George Yesterday the UK Government announced a landmark UK-US pharmaceutical trade deal designed to safeguard medicines access and reinforce the UK’s position as a life sciences superpower. The deal delivers headline commitments that have been widely welcomed by industry: · Zero tariffs on pharmaceutical exports · A reduced VPAG …
The OVID team were proud to support Tillotts Pharma UK in launching the A Chronic Cost campaign in Parliament yesterday. Hosted by Baroness Young of Old Scone, the event shone a spotlight on the impact of prescription charges on people living with inflammatory bowel disease (IBD) in England. Featuring powerful insights from the IBD community, …
An OVID Health article by Anna Parnanen Recently, the Cell and Gene Therapy Catapult and the Advanced Therapy Treatment Centre (ATTC) network brought the ATMP community together for “Shaping a stronger UK ecosystem for advanced therapy clinical trials.” OVID Health acts as a secretariat to the Cell and Gene Collective (CGC), an alliance of five …
We’re an award-winning global specialist healthcare communications consultancy, creators of the Patient Advocacy & Centricity Tracker tool and founders of the global Patient Partnership Index.
OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO
OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO
